MedPath

TECHPOOL BIO-PHARMA CO., LTD.

TECHPOOL BIO-PHARMA CO., LTD. logo
🇨🇳China
Ownership
Joint Venture, Subsidiary
Established
1993-03-25
Employees
1K
Market Cap
-
Website
http://www.techpool.com.cn

Clinical Trials

5

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:1
Phase 4:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (75.0%)
Phase 2
1 (25.0%)

The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)

Phase 2
Conditions
Acute Respiratory Distress Syndrome
Interventions
Drug: placebo
First Posted Date
2016-09-09
Last Posted Date
2018-04-20
Lead Sponsor
Techpool Bio-Pharma Co., Ltd.
Target Recruit Count
60
Registration Number
NCT02895191
Locations
🇨🇳

The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China

🇨🇳

Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

Guangzhou First People's Hospital, Guangzhou, Guangdong, China

and more 8 locations

The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein

Phase 4
Conditions
Cerebral Infarction
Interventions
First Posted Date
2015-09-29
Last Posted Date
2018-01-17
Lead Sponsor
Techpool Bio-Pharma Co., Ltd.
Target Recruit Count
2186
Registration Number
NCT02562183
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

🇨🇳

NO.2 Hospital XiaMen, Xiamen, Fujian, China

🇨🇳

HanDan Central Hospital, Handan, Hebei, China

and more 4 locations

Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery

Phase 4
Conditions
Congenital Heart Diseases
Interventions
First Posted Date
2015-08-19
Last Posted Date
2018-01-17
Lead Sponsor
Techpool Bio-Pharma Co., Ltd.
Target Recruit Count
450
Registration Number
NCT02527811
Locations
🇨🇳

General Hospital of Guangzhou Millitary Command, Guangzhou, Guangdong, China

🇨🇳

Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China

🇨🇳

Nanjing Children's Hospital, Nanjing, Jiangsu, China

and more 2 locations

Post-market Safety Reassessment of Ulinastatin for Injection

Conditions
Adverse Reaction to Drug
Interventions
First Posted Date
2015-08-13
Last Posted Date
2018-04-23
Lead Sponsor
Techpool Bio-Pharma Co., Ltd.
Target Recruit Count
10000
Registration Number
NCT02520570
Locations
🇨🇳

Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China

Ulinastatin in Severe Acute Pancreatitis

Phase 4
Suspended
Conditions
Pancreatitis
Interventions
Drug: placebo
First Posted Date
2010-05-28
Last Posted Date
2018-01-17
Lead Sponsor
Techpool Bio-Pharma Co., Ltd.
Target Recruit Count
252
Registration Number
NCT01132521
Locations
🇨🇳

The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

🇨🇳

The First Clinical College of Harbin University, Harbin, Heilongjiang, China

🇨🇳

Wuhan Union Hospital of China, Wuhan, Hubei, China

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.